Which company was the first to receive FDA approval for a CRISPR-based therapeutic treatment in the United States?

CRISPR gene-editing technology has transformed biotechnology and pharmaceutical research since its breakthrough discovery. This revolutionary tool has not only changed scientific research but also created a competitive market for companies developing CRISPR-based products and therapeutics. Test your knowledge about the commercial landscape of this cutting-edge scientific technology.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Vertex Pharmaceuticals & CRISPR Therapeutics (for CASGEVY/exagamglogene autotemcel)
Editas Medicine (for EDIT-101)
Intellia Therapeutics (for NTLA-2001)
Beam Therapeutics (for BEAM-101)